Saint Petersburg, Florida, September 29, 2026 - Stemedix is highlighting new developments in research on stem cell therapy and its potential role in addressing neuropathic pain and damaged nerves. The clinic’s latest educational focus brings attention to conditions such as diabetic peripheral neuropathy, chemotherapy-related nerve damage, nerve injuries, and sciatica linked to nerve compression, while also noting the limits of current human evidence.

Neuropathic pain develops when nerves are damaged or do not function normally. Symptoms can include burning, tingling, numbness, sensitivity, weakness, and shooting pain. As researchers continue studying regenerative approaches, stem cell treatment is being investigated as a possible way to support the environment around damaged nerve tissue.

Neuropathic Pain Drives New Nerve Repair Research

Diabetic peripheral neuropathy is one of the most common forms of nerve damage associated with diabetes. Research published by Springer Nature reports that diabetic peripheral neuropathy may affect up to 50% of people with diabetes.

Other forms of neuropathic pain can develop after chemotherapy, surgery, physical trauma, or nerve compression. The range of conditions has increased interest in treatments that may support nerve health rather than focusing only on symptom management.

For patients exploring stem cell therapy in Saint Petersburg, FL, the distinction between established treatment and developing research remains important. Different nerve conditions have different causes, and a treatment that is being studied for one type of nerve injury may not apply to another.

Stem Cells and the Nerve Repair Process

Researchers are studying several possible ways mesenchymal stem cells may affect damaged nerve tissue. These cells are not simply expected to replace injured nerves. Instead, research suggests they may release signals and growth factors that affect nearby tissue.

Areas being studied include:

• Reducing inflammation around damaged nerves

• Supporting nerve cell survival

• Encouraging axon regeneration

• Supporting the rebuilding of myelin around nerve fibers

• Promoting blood vessel development near injured tissue

These processes may create a more supportive environment for nerve repair. However, much of the evidence remains preclinical, meaning it comes from laboratory and animal research rather than large human clinical trials.

Preclinical Findings Show Areas of Interest

A systematic review and meta-analysis examined 27 preclinical studies involving 722 animals and found that adding mesenchymal stem cells to peripheral nerve repair was associated with improved nerve conduction velocity recovery and other measures of nerve regeneration. The researchers reported a statistically significant improvement in nerve conduction velocity recovery, with p = 0.009.

The researchers also noted that further studies are needed to determine whether these findings translate into meaningful clinical benefits for people.

Stem Cell Treatment Remains an Area of Study

The developing research does not mean that stem cell therapy can repair every damaged nerve or provide the same result for every patient. Nerve damage varies by cause, location, and severity, and regeneration can take months.

“Research into nerve repair is developing, but it is important to distinguish promising research from established clinical outcomes,” said Fred Palmer, CEO of Stemedix. “Our focus is on reviewing each patient’s diagnosed condition and medical history so that any regenerative medicine option can be considered in the proper clinical context.”

At Stemedix, patients seeking stem cell therapy in Saint Petersburg, FL, are asked to provide relevant medical records, bloodwork, imaging, and other available information. Care Coordinators help with the records process, while board-certified providers review the information and determine whether a regenerative medicine option may be appropriate.

Conditions Studied With Stem Cell Therapy

Research and clinical discussion around regenerative approaches include several forms of nerve-related conditions, including:

• Diabetic peripheral neuropathy

• Chemotherapy-induced peripheral neuropathy

• Post-surgical or post-traumatic nerve injury

• Sciatica related to nerve compression

• Complex regional pain syndrome

• Certain forms of facial neuropathic pain

The level of evidence differs across these conditions. Some findings come from early human studies, while other research remains limited to laboratory or animal models.

About Stemedix

Stemedix was founded in 2013 and is headquartered in St. Petersburg, Florida. The organization provides regenerative medicine services in Florida and Seattle and works with board-certified providers. Its cellular science team has more than 25 years of experience. The clinic focuses on regenerative medicine and provides individualized treatment options based on a patient's medical history and diagnosed condition.

Media Contact

Fred Palmer

CEO, Stemedix

Bayfront Medical Plaza 601

7th Street S. Suite 565

Florida, Saint Petersburg 33701

Phone: (727) 456-8968

Email: yourjourney@stemedix.com

Contact Page: https://stemedix.com/contact/

Contact Information:

Stemedix

Bayfront Medical Plaza 601 7th Street S. Suite 565
Saint Petersburg, FL 33701
United States

Fred Palmer
https://stemedix.com/